About: Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes
Creator	Clark, Nina Reid, Gail Belperio, John Grim, Shellee Lynch Iii, Joseph Singh, Sunit Sayah, David Weigt, Samuel
Source	PMC
abstract	Among immunocompromised individuals, members of the human Herpesviridae family are frequently encountered pathogens. Cytomegalovirus, herpes simplex virus 1 and 2, varicella zoster virus, Epstein–Barr virus, and human herpesvirus-6, -7, and -8 all establish latency after infection and can reactivate during periods of immunosuppression, leading to both direct and indirect adverse effects on the host including severe organ dysfunction as well as allograft rejection and loss after transplantation. While not all herpesviruses are primary respiratory pathogens, many of their manifestations include involvement of the respiratory tract. This article discusses the individual viruses, their epidemiology, and clinical manifestations as well as recommended treatment and preventive strategies.
has issue date	2016-08-01(xsd:dateTime)
bibo:doi	10.1055/s-0036-1584793
bibo:pmid	27486740
has license	no-cc
sha1sum (hex)	26efe2480c96d93ed23f8adf49ace5671c55d6d1
schema:url	https://doi.org/10.1055/s-0036-1584793
resource representing a document's title	Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes
has PubMed Central identifier	PMC7171758
has PubMed identifier	27486740
schema:publication	Semin Respir Crit Care Med
resource representing a document's body	covid:26efe2480c96d93ed23f8adf49ace5671c55d6d1#body_text
is schema:about of	named entity 'EBV' named entity 'Patients' named entity 'CELL TRANSPLANT' named entity 'SETTINGS' named entity 'PATIENTS' named entity 'HEMATOPOIETIC CELL' covid:arg/26efe2480c96d93ed23f8adf49ace5671c55d6d1 named entity 'complication' named entity 'virus' named entity 'addition' named entity 'focus' named entity 'burden' named entity 'burden of disease' named entity 'Epstein-Barr' named entity 'immunosuppressive therapy' named entity 'hematopoietic cell' named entity 'pulmonary infection' named entity 'preventive strategies' named entity 'atypical' named entity 'PEL' named entity 'cell cycle progression' named entity 'valganciclovir' named entity 'DNA polymerase' named entity 'sub-Saharan' named entity 'MCD' named entity 'HHV-6' named entity 'hematological malignancies' named entity 'lytic' named entity 'CMV' named entity 'prognosis' named entity 'HHV-6' named entity 'EBV' named entity 'Varicella-zoster virus' named entity 'immunosuppressive therapy' named entity 'prophylaxis' named entity 'EBV' named entity 'EBV' named entity 'pneumonia' named entity 'placebo' named entity 'viremia' named entity 'prophylaxis' named entity 'endemic' named entity 'clinical symptoms' named entity 'lymphoproliferative disorder' named entity 'HHV-6' named entity 'PCR' named entity 'Seizures' named entity 'infection' named entity 'PTLD' named entity 'HIV' named entity 'acyclovir' named entity 'lymphoid cells' named entity 'renal transplant' named entity 'staging systems' named entity 'immune globulin' named entity 'pediatric' named entity 'histologically' named entity 'CD138' named entity 'febrile illness' named entity 'ulceration' named entity 'phase 3 trial' named entity 'EBV' named entity 'MCD' named entity 'HIV' named entity 'signs and symptoms' named entity 'CD20' named entity 'PCR' named entity 'nephrotoxic' named entity 'neurologic' named entity 'chemotherapy' named entity 'CD4' named entity 'CMV' named entity 'rituximab' named entity 'CMV'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software